Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
As of close of business last night, Sutro Biopharma Inc’s stock clocked out at $1.85, down -5.13% from its previous closing price of $1.95. In other words, the price has decreased by -$5.13 from its previous closing price. On the day, 0.95 million shares were traded. STRO stock price reached its highest trading level at $1.95 during the session, while it also had its lowest trading level at $1.78.
Ratios:
To gain a deeper understanding of STRO’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.09 and its Current Ratio is at 3.09. In the meantime, Its Debt-to-Equity ratio is 1.77 whereas as Long-Term Debt/Eq ratio is at 1.70.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BofA Securities on May 08, 2024, initiated with a Buy rating and assigned the stock a target price of $12.
On November 09, 2023, Deutsche Bank started tracking the stock assigning a Buy rating and target price of $12.
On October 06, 2023, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $10.Oppenheimer initiated its Outperform rating on October 06, 2023, with a $10 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jan 29 ’24 when Vasquez Nicki sold 12,185 shares for $5.00 per share. The transaction valued at 60,925 led to the insider holds 12,803 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, STRO now has a Market Capitalization of 152548608 and an Enterprise Value of -210841360. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.95 while its Price-to-Book (P/B) ratio in mrq is 1.37. Its current Enterprise Value per Revenue stands at -1.31 whereas that against EBITDA is 1.715.
Stock Price History:
The Beta on a monthly basis for STRO is 1.15, which has changed by -0.52196383 over the last 52 weeks, in comparison to a change of 0.22263205 over the same period for the S&P500. Over the past 52 weeks, STRO has reached a high of $6.13, while it has fallen to a 52-week low of $1.70. The 50-Day Moving Average of the stock is -31.64%, while the 200-Day Moving Average is calculated to be -48.74%.
Shares Statistics:
It appears that STRO traded 935.14K shares on average per day over the past three months and 823690 shares per day over the past ten days. A total of 82.40M shares are outstanding, with a floating share count of 76.30M. Insiders hold about 7.47% of the company’s shares, while institutions hold 69.79% stake in the company. Shares short for STRO as of 1734048000 were 2457607 with a Short Ratio of 3.37, compared to 1731628800 on 1788700. Therefore, it implies a Short% of Shares Outstanding of 2457607 and a Short% of Float of 3.01.
